{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:02:28Z","timestamp":1780038148293,"version":"3.53.1"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Renal denervation (RDN) is a catheter-based interventional approach that targets renal sympathetic nerves to modulate sympathetic overactivity, a key pathophysiological driver of resistant hypertension and associated cardiovascular complications. In contrast to pharmacological approaches, the therapeutic effect of RDN does not rely on patient adherence. Originally indicated for severe resistant hypertension, RDN has since shown consistent antihypertensive efficacy across a broad range of hypertensive patients in recent sham-controlled studies. In this review, we discuss the pathophysiological foundation underlying RDN, consolidate the current clinical evidence supporting its therapeutic efficacy, describe the spectrum of available ablation technologies, and evaluate its expanding applications in conditions driven by sympathetic overactivity.<\/jats:p>","DOI":"10.3389\/fcvm.2026.1844520","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:10:22Z","timestamp":1780035022000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Repositioning renal denervation in resistant hypertension: evidence-based insights, stratified decision-making, and implementation pathways"],"prefix":"10.3389","volume":"13","author":[{"given":"Min","family":"Li","sequence":"first","affiliation":[{"name":"Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cheng","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wei","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"2019 Diseases and injuries collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u22122019: a systematic analysis for the global burden of disease study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.jacc.2023.08.045","article-title":"Safety and efficacy of renal denervation in patients taking antihypertensive medications","volume":"82","author":"Kandzari","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/heartjnl-2018-313599","article-title":"Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients","volume":"105","author":"Noubiap","year":"2019","journal-title":"Heart"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e07","DOI":"10.15420\/ecr.2023.51","article-title":"The global burden of resistant hypertension and potential treatment options","volume":"19","author":"Buso","year":"2024","journal-title":"Eur Cardiol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11906-023-01282-0","article-title":"Resistant hypertension: disease burden and emerging treatment options","volume":"26","author":"Flack","year":"2024","journal-title":"Curr Hypertens Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.2147\/PPA.S368784","article-title":"A critical review of medication adherence in hypertension: barriers and facilitators clinicians should consider","volume":"16","author":"Hamrahian","year":"2022","journal-title":"Patient Prefer Adherence"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e026582","DOI":"10.1161\/JAHA.122.026582","article-title":"Global burden, regional differences, trends, and health consequences of medication nonadherence for hypertension during 2010 to 2020: a meta-analysis involving 27 million patients","volume":"11","author":"Lee","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.118.313220","article-title":"Adherence in hypertension","volume":"124","author":"Burnier","year":"2019","journal-title":"Circ Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1161\/HYPERTENSIONAHA.123.21347","article-title":"Sympathetic pathophysiology in hypertension origins: the path to renal denervation","volume":"81","author":"Esler","year":"2024","journal-title":"Hypertension"},{"key":"B12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1113\/expphysiol.2014.079889","article-title":"The crosstalk between the kidney and the central nervous system: the role of renal nerves in blood pressure regulation","volume":"100","author":"Nishi","year":"2015","journal-title":"Exp Physiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/cphy.c150047","article-title":"Renal nerves and long-term control of arterial pressure","volume":"7","author":"Osborn","year":"2017","journal-title":"Compr Physiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ahj.2023.12.005","article-title":"Overview of the 2023 FDA circulatory system devices advisory panel meeting on the symplicity spyral renal denervation system","volume":"269","author":"Chitturi","year":"2024","journal-title":"Am Heart J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1038\/s41440-024-01949-4","article-title":"Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trials","volume":"47","author":"Schmieder","year":"2024","journal-title":"Hypertens Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(22)01787-1","article-title":"Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 trial","volume":"400","author":"Bhatt","year":"2022","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMc0904179","article-title":"Renal sympathetic-nerve ablation for uncontrolled hypertension","volume":"361","author":"Schlaich","year":"2009","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jacc.2014.03.059","article-title":"Anatomic assessment of sympathetic peri-arterial renal nerves in man","volume":"64","author":"Sakakura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"E32","DOI":"10.1002\/ccd.26035","article-title":"Post mortem study of the depth and circumferential location of sympathetic nerves in human renal arteries\u2013implications for renal denervation catheter design","volume":"86","author":"Roy","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"B20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1152\/physrev.1997.77.1.75","article-title":"Neural control of renal function","volume":"77","author":"DiBona","year":"1997","journal-title":"Physiol Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1152\/ajpregu.00351.2014","article-title":"Role of renal sensory nerves in physiological and pathophysiological conditions","volume":"308","author":"Kopp","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1161\/CIRCRESAHA.116.303604","article-title":"The sympathetic nervous system alterations in human hypertension","volume":"116","author":"Grassi","year":"2015","journal-title":"Circ Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4244\/AIJ-D-21-00013","article-title":"Renal denervation therapy for hypertension: truths and half-truths: renal denervation therapy for hypertension","volume":"7","author":"Ram","year":"2021","journal-title":"AsiaIntervention"},{"key":"B24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.carrev.2022.02.018","article-title":"Time, temperature, power, and impedance considerations for radiofrequency catheter renal denervation","volume":"42","author":"Coates","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1161\/CIRCULATIONAHA.118.037654","article-title":"A three-arm randomized trial of different renal denervation devices and techniques in patients with resistant hypertension (RADIOSOUND-HTN)","volume":"139","author":"Fengler","year":"2019","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4244\/EIJV9I1A20","article-title":"Ethanol-mediated perivascular renal sympathetic denervation: preclinical validation of safety and efficacy in a porcine model","volume":"9","author":"Fischell","year":"2013","journal-title":"EuroIntervention"},{"key":"B27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jcin.2015.12.278","article-title":"Transcatheter alcohol-mediated perivascular renal denervation with the peregrine system first-in-human study","volume":"9","author":"Fischell","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/S0140-6736(22)00455-X","article-title":"Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial","volume":"399","author":"Mahfoud","year":"2022","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1161\/HYPERTENSIONAHA.119.12680","article-title":"Selective renal denervation guided by renal nerve stimulation in canine: a method for identification of optimal ablation target","volume":"74","author":"Liu","year":"2019","journal-title":"Hypertension"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1016\/j.jacc.2018.08.2186","article-title":"Renal denervation prevents heart failure progression via inhibition of the renin-angiotensin system","volume":"72","author":"Sharp","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e70112","DOI":"10.1111\/jch.70112","article-title":"Long-term electrocardiographic changes following renal denervation-left ventricular mass and arrhythmia burden","volume":"27","author":"Sesa-Ashton","year":"2025","journal-title":"J Clin Hypertens"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/j.jacep.2024.04.035","article-title":"Long-term changes in atrial arrhythmia burden after renal denervation combined with pulmonary vein isolation: SYMPLICITY-AF","volume":"10","author":"Chinitz","year":"2024","journal-title":"JACC Clin Electrophysiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"oeae065","DOI":"10.1093\/ehjopen\/oeae065","article-title":"Efficacy of renal denervation as an adjunct to pulmonary vein isolation for atrial fibrillation treatment: a systematic review and meta-analysis","volume":"4","author":"Thavabalan","year":"2024","journal-title":"Eur Heart J Open"},{"key":"B34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.14744\/AnatolJCardiol.2025.5097","article-title":"Effect of combined renal denervation and pulmonary vein isolation on atrial fibrillation: a systematic meta-analysis","volume":"29","author":"Zhai","year":"2025","journal-title":"Anatol J Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1001\/jama.2019.21187","article-title":"Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: the ERADICATE-AF randomized clinical trial","volume":"323","author":"Steinberg","year":"2020","journal-title":"JAMA"},{"key":"B36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00592-023-02208-7","article-title":"Unravelling the effect of renal denervation on glucose homeostasis: more questions than answers?","volume":"61","author":"Koutra","year":"2024","journal-title":"Acta Diabetol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"sfaf184","DOI":"10.1093\/ckj\/sfaf184","article-title":"Effect of renal denervation on glucose metabolism in hypertensive patients with and without chronic kidney disease","volume":"18","author":"Bytyqi","year":"2025","journal-title":"Clin Kidney J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1093\/eurheartj\/ehz118","article-title":"Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the global SYMPLICITY registry","volume":"40","author":"Mahfoud","year":"2019","journal-title":"Eur Heart J"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","article-title":"Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED pivotal): a multicentre, randomised, sham-controlled trial","volume":"395","author":"B\u00f6hm","year":"2020","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e015194","DOI":"10.1161\/CIRCINTERVENTIONS.125.015194","article-title":"Long-term safety and efficacy of renal denervation: 24-month results from the SPYRAL HTN-ON MED trial","volume":"18","author":"Kandzari","year":"2025","journal-title":"Circ Cardiovasc Interv"},{"key":"B41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41440-022-01042-8","article-title":"Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial","volume":"46","author":"Kario","year":"2023","journal-title":"Hypertens Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","article-title":"Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial","volume":"391","author":"Azizi","year":"2018","journal-title":"Lancet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/S0140-6736(21)00788-1","article-title":"Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial","volume":"397","author":"Azizi","year":"2021","journal-title":"Lancet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/jama.2023.0713","article-title":"Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial","volume":"329","author":"Azizi","year":"2023","journal-title":"JAMA"},{"key":"B45","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data","volume":"384","year":"2014","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/j.jacc.2020.04.036","article-title":"Renal denervation in high-risk patients with hypertension","volume":"75","author":"Mahfoud","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B49","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1161\/CIRCINTERVENTIONS.114.001506","article-title":"Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries","volume":"7","author":"Mahfoud","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/s41440-025-02186-z","article-title":"Two-year nighttime blood pressure changes after radiofrequency renal denervation: pooled results from the SPYRAL HTN trials","volume":"48","author":"Kario","year":"2025","journal-title":"Hypertens Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/HYPERTENSIONAHA.118.11180","article-title":"Renal denervation in resistant hypertension and obstructive sleep apnea: randomized proof-of-concept phase II trial","volume":"72","author":"Warchol-Celinska","year":"2018","journal-title":"Hypertension"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.jacc.2016.01.037","article-title":"Morning home blood pressure is a strong predictor of coronary artery disease: the HONEST study","volume":"67","author":"Kario","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00392-020-01718-6","article-title":"Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial","volume":"110","author":"Kario","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.carrev.2016.07.009","article-title":"Accessory renal arteries: prevalence in resistant hypertension and an important role in nonresponse to radiofrequency renal denervation","volume":"17","author":"VonAchen","year":"2016","journal-title":"Cardiovasc Revasc Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/ndt\/gfae041","article-title":"A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European society of hypertension (ESH) guidelines for the management of arterial hypertension","volume":"39","author":"Sarafidis","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"ESC Scientific document group. 2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1161\/HYPERTENSIONAHA.125.25470","article-title":"Renal denervation in patients with moderate to severe chronic kidney disease","volume":"82","author":"Schlaich","year":"2025","journal-title":"Hypertension"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s40620-025-02406-2","article-title":"The role of renal denervation for the treatment of hypertension in patients with chronic kidney disease: a position paper of the Italian society of nephrology","volume":"38","author":"Feriozzi","year":"2025","journal-title":"J Nephrol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jcin.2022.10.058","article-title":"6- And 12-month follow-up from a randomized clinical trial of ultrasound vs radiofrequency renal denervation (RADIOSOUND-HTN)","volume":"16","author":"Fengler","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"B60","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1038\/s41598-019-41159-4","article-title":"Anatomic conformation of renal sympathetic nerve fibers in living human tissues","volume":"9","author":"Choe","year":"2019","journal-title":"Sci Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1038\/s41440-024-01801-9","article-title":"Differences in the effectiveness and safety of different renal denervation devices","volume":"47","author":"Ogoyama","year":"2024","journal-title":"Hypertens Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jash.2012.04.004","article-title":"Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial","volume":"6","author":"Hoppe","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"B63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1161\/HYPERTENSIONAHA.111.00064","article-title":"The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases","volume":"61","author":"Paton","year":"2013","journal-title":"Hypertension"},{"key":"B64","doi-asserted-by":"publisher","first-page":"100830","DOI":"10.1016\/j.jscai.2023.100830","article-title":"SCAI position statement on renal denervation for hypertension: patient selection, operator competence, training and techniques, and organizational recommendations","volume":"2","author":"Swaminathan","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41569-024-01104-z","article-title":"Renal denervation for hypertension","volume":"22","author":"Fisher","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1161\/HYPERTENSIONAHA.123.21283","article-title":"Outcomes following radiofrequency renal denervation according to antihypertensive medications: subgroup analysis of the global SYMPLICITY registry DEFINE","volume":"80","author":"Mahfoud","year":"2023","journal-title":"Hypertension"},{"key":"B67","doi-asserted-by":"publisher","first-page":"102234","DOI":"10.1016\/j.jscai.2024.102234","article-title":"Catheter-based radiofrequency renal denervation in the United States: a cost-effectiveness analysis based on contemporary evidence","volume":"3","author":"Kandzari","year":"2024","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"B68","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s41669-024-00472-z","article-title":"Cost effectiveness of endovascular ultrasound renal denervation in patients with resistant hypertension","volume":"8","author":"Taylor","year":"2024","journal-title":"Pharmacoecon Open"},{"key":"B69","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/13696998.2024.2441072","article-title":"Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Canada","volume":"28","author":"McFarlane","year":"2025","journal-title":"J Med Econ"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s00392-023-02325-x","article-title":"Real-world experience with ultrasound renal denervation utilizing home blood pressure monitoring: the global paradise system registry study design","volume":"113","author":"Mahfoud","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e034915","DOI":"10.1161\/JAHA.124.034915","article-title":"Patient-specific factors predicting renal denervation response in patients with hypertension: a systematic review and meta-analysis","volume":"13","author":"Hu","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"B72","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA","article-title":"Response of blood pressure to renal denervation is not associated with genetic variants","volume":"82","author":"Delles","year":"2025","journal-title":"Hypertension"},{"key":"B73","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/1354750X.2016.1172112","article-title":"Biomarker response and therapy prediction in renal denervation therapy\u2014the role of MR-proadrenomedullin in a multicenter approach","volume":"22","author":"Neumann","year":"2017","journal-title":"Biomarkers"},{"key":"B74","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/ccd.27158","article-title":"Acute changes in histopathology and intravascular imaging after catheter-based renal denervation in a porcine model","volume":"90","author":"Sakaoka","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1161\/HYPERTENSIONAHA.120.15325","article-title":"Quantification of renal sympathetic vasomotion as a novel end point for renal denervation","volume":"76","author":"Pellegrino","year":"2020","journal-title":"Hypertension"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/s41440-024-01598-7","article-title":"Does renal denervation require cardiovascular outcome-driven data?","volume":"47","author":"Haider","year":"2024","journal-title":"Hypertens Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/ehjqcco\/qcac056","article-title":"Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry","volume":"9","author":"Schmieder","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Engl J Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/S0140-6736(18)30951-6","article-title":"Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial","volume":"391","year":"2018","journal-title":"Lancet"},{"key":"B80","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41440-021-00754-7","article-title":"Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial","volume":"45","author":"Kario","year":"2022","journal-title":"Hypertens Res"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1844520\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:10:24Z","timestamp":1780035024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1844520\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":80,"alternative-id":["10.3389\/fcvm.2026.1844520"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1844520","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1844520"}}